SCHEMBL8270076

SCHEMBL8270076

CCOC(=O)CCNc1nc(-c2ccc(-c3ccccc3OCC)cc2)nc2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.68
SMN1; SMN2 Q16637 2/20 0.57
HPGD P15428 1/20 0.57
PDE10A Q9Y233 1/20 0.57
MAPT P10636 4/20 0.56
KDM4E B2RXH2 4/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
GBA1 P04062 3/20 0.56
ALDH1A1 P00352 3/20 0.56
PIP4K2A P48426 1/20 0.55
SIRT5 Q9NXA8 1/20 0.54
TOP2A P11388 1/20 0.54
RECQL P46063 2/20 0.53
TP53 P04637 2/20 0.53
CYP1A2 P05177 3/20 0.49
ALOX15 P16050 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
CYP2D6 P10635 1/20 0.49
MAPK1 P28482 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8268365 0.94 PDE5A (0.78) PDE5ASMN1; SMN2HPGDPDE10AMAPT
SCHEMBL8268880 0.92 PDE5A (0.68) PDE5ASMN1; SMN2HPGDMAPTKDM4E
SCHEMBL8268376 0.90 PDE10A (0.56) PDE5APDE10AALDH1A1PIP4K2ATDP1
SCHEMBL8268379 0.87 PDE5A (0.64) PDE5ASMN1; SMN2PDE10AMAPTKDM4E
SCHEMBL8269875 0.87 PDE5A (0.78) PDE5ASMN1; SMN2HPGDMAPTKDM4E
SCHEMBL8270097 0.86 PDE5A (0.67) PDE5ASMN1; SMN2HPGDMAPTKDM4E
SCHEMBL8268892 0.85 PIP4K2A (0.59) PDE5ASMN1; SMN2HPGDPDE10AMAPT
SCHEMBL8268888 0.85 PDE5A (0.75) PDE5ASMN1; SMN2HPGDMAPTKDM4E
SCHEMBL8268896 0.85 PDE5A (0.64) PDE5APDE10AALDH1A1PIP4K2ATOP2A
SCHEMBL8269892 0.83 PIP4K2A (0.53) PDE5ASMN1; SMN2HPGDPDE10AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006034512-A2 PHENYL-SUBSTITUTED QUINOLINE AND QUINAZOLINE COMPOUNDS FOR THE TREATMENT OF DIABETES BAYER PHARMACEUTICALS CORPORATION (US) 2006-03-30 WO disclosed